Literature DB >> 7730449

IgG anti-GM1 antibodies from patients with acute motor neuropathy are predominantly of the IgG1 and IgG3 subclasses.

M Ogino1, N Orazio, N Latov.   

Abstract

Increased titers of IgG anti-GM1 and anti-asialo GM1 (GA1) ganglioside antibodies are present in some patients with the Guillain-Barré syndrome, particularly with the motor axonal variant, and following infection with Campylobacter jejuni or parenteral administration of gangliosides. The subclass distribution of IgG anti-GM1 or GA1 antibodies from 19 patients with acute motor neuropathy and elevated antibody titers were measured by ELISA using mouse monoclonal antibodies specific for human IgG subclasses. The anti-GM1 or GA1 antibodies were predominantly of the IgG1 and IgG3 subclasses, which are capable of complement fixation, and are characteristic of a T cell-dependent antibody response.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7730449     DOI: 10.1016/0165-5728(94)00190-y

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  9 in total

Review 1.  Guillain Barré syndrome.

Authors:  J B Winer
Journal:  Mol Pathol       Date:  2001-12

2.  Distinct immunoglobulin class and immunoglobulin G subclass patterns against ganglioside GQ1b in Miller Fisher syndrome following different types of infection.

Authors:  B Schwerer; A Neisser; H Bernheimer
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Lack of association between autism and anti-GM1 ganglioside antibody.

Authors:  Sina Moeller; Nga M Lau; Peter H R Green; Dan Hellberg; Joseph J Higgins; Anjali M Rajadhyaksha; Armin Alaedini
Journal:  Neurology       Date:  2013-09-25       Impact factor: 9.910

4.  Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits.

Authors:  C W Ang; M A De Klerk; H P Endtz; B C Jacobs; J D Laman; F G van der Meché; P A van Doorn
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

5.  Anti-ganglioside GM1 antibody and distal symmetric "diabetic polyneuropathy" with dominant motor features.

Authors:  Z Milicevic; P G Newlon; G L Pittenger; K B Stansberry; A I Vinik
Journal:  Diabetologia       Date:  1997-11       Impact factor: 10.122

Review 6.  Guillain-Barré syndrome: expanding the concept of molecular mimicry.

Authors:  Jon D Laman; Ruth Huizinga; Geert-Jan Boons; Bart C Jacobs
Journal:  Trends Immunol       Date:  2022-03-04       Impact factor: 19.709

7.  Lewis rats immunized with GM1 ganglioside do not develop peripheral neuropathy.

Authors:  Amjad A Ilyas; Zi-Wei Chen
Journal:  J Neuroimmunol       Date:  2007-06-07       Impact factor: 3.478

Review 8.  Molecular mimicry in multiple sclerosis.

Authors:  Jane E Libbey; Lori L McCoy; Robert S Fujinami
Journal:  Int Rev Neurobiol       Date:  2007       Impact factor: 3.230

9.  Neurological disorders-associated anti-glycosphingolipid IgG-antibodies display differentially restricted IgG subclass distribution.

Authors:  Ricardo D Lardone; Fernando J Irazoqui; Gustavo A Nores
Journal:  Sci Rep       Date:  2020-08-04       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.